Pulse Biosciences, Inc. (PLSE) Tops Q1 EPS by 3c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q1 EPS of ($0.27), $0.03 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $400 thousand versus the consensus estimate of $400 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• Faraday Future unveils nine robot models, prices start at $9,990
• FortuneX and WT Realty announce $600M merger deal
• Honeywell wins $53.9M Navy contract for navigation parts